Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)

CompletedOBSERVATIONAL

Enrollment

133

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Psoriasis

Interventions

BIOLOGICAL

Infliximab

According to local country regulations.

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00749398 - Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) | Biotech Hunter | Biotech Hunter